These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 10753878

  • 1. Activation of NF-kappaB by FADD, Casper, and caspase-8.
    Hu WH, Johnson H, Shu HB.
    J Biol Chem; 2000 Apr 14; 275(15):10838-44. PubMed ID: 10753878
    [Abstract] [Full Text] [Related]

  • 2. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
    Harper N, Hughes M, MacFarlane M, Cohen GM.
    J Biol Chem; 2003 Jul 11; 278(28):25534-41. PubMed ID: 12721308
    [Abstract] [Full Text] [Related]

  • 3. Activation of death-inducing signaling complex (DISC) by pro-apoptotic C-terminal fragment of RIP.
    Kim JW, Choi EJ, Joe CO.
    Oncogene; 2000 Sep 14; 19(39):4491-9. PubMed ID: 11002422
    [Abstract] [Full Text] [Related]

  • 4. Casper is a FADD- and caspase-related inducer of apoptosis.
    Shu HB, Halpin DR, Goeddel DV.
    Immunity; 1997 Jun 14; 6(6):751-63. PubMed ID: 9208847
    [Abstract] [Full Text] [Related]

  • 5. Activation of the NF-kappaB pathway by caspase 8 and its homologs.
    Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, Hood L.
    Oncogene; 2000 Sep 14; 19(39):4451-60. PubMed ID: 11002417
    [Abstract] [Full Text] [Related]

  • 6. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development.
    Yeh WC, Itie A, Elia AJ, Ng M, Shu HB, Wakeham A, Mirtsos C, Suzuki N, Bonnard M, Goeddel DV, Mak TW.
    Immunity; 2000 Jun 14; 12(6):633-42. PubMed ID: 10894163
    [Abstract] [Full Text] [Related]

  • 7. Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha.
    Imamura R, Konaka K, Matsumoto N, Hasegawa M, Fukui M, Mukaida N, Kinoshita T, Suda T.
    J Biol Chem; 2004 Nov 05; 279(45):46415-23. PubMed ID: 15337758
    [Abstract] [Full Text] [Related]

  • 8. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS, Schwabe RF, Qian T, Lemasters JJ, Brenner DA.
    Hepatology; 2002 Dec 05; 36(6):1498-508. PubMed ID: 12447876
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).
    Wajant H, Haas E, Schwenzer R, Muhlenbeck F, Kreuz S, Schubert G, Grell M, Smith C, Scheurich P.
    J Biol Chem; 2000 Aug 11; 275(32):24357-66. PubMed ID: 10823821
    [Abstract] [Full Text] [Related]

  • 10. Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation.
    Wang Y, Wu TR, Cai S, Welte T, Chin YE.
    Mol Cell Biol; 2000 Jul 11; 20(13):4505-12. PubMed ID: 10848577
    [Abstract] [Full Text] [Related]

  • 11. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways.
    Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M, Tschopp J.
    Curr Biol; 2000 Jun 01; 10(11):640-8. PubMed ID: 10837247
    [Abstract] [Full Text] [Related]

  • 12. Casper/c-FLIP is physically and functionally associated with NF-kappaB1 p105.
    Li Z, Zhang J, Chen D, Shu HB.
    Biochem Biophys Res Commun; 2003 Oct 03; 309(4):980-5. PubMed ID: 13679070
    [Abstract] [Full Text] [Related]

  • 13. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.
    Harper N, Hughes MA, Farrow SN, Cohen GM, MacFarlane M.
    J Biol Chem; 2003 Nov 07; 278(45):44338-47. PubMed ID: 12920112
    [Abstract] [Full Text] [Related]

  • 14. N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway.
    Kataoka T, Tschopp J.
    Mol Cell Biol; 2004 Apr 07; 24(7):2627-36. PubMed ID: 15024054
    [Abstract] [Full Text] [Related]

  • 15. Xenopus death-domain-containing proteins FADD and RIP1 synergistically activate JNK and NF-kappaB.
    Ishizawa YH, Tamura K, Yamaguchi T, Matsumoto K, Komiyama M, Takamatsu N, Shiba T, Ito M.
    Biol Cell; 2006 Aug 07; 98(8):465-78. PubMed ID: 16597320
    [Abstract] [Full Text] [Related]

  • 16. Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression.
    Lüschen S, Ussat S, Scherer G, Kabelitz D, Adam-Klages S.
    J Biol Chem; 2000 Aug 11; 275(32):24670-8. PubMed ID: 10827087
    [Abstract] [Full Text] [Related]

  • 17. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
    Heyninck K, De Valck D, Vanden Berghe W, Van Criekinge W, Contreras R, Fiers W, Haegeman G, Beyaert R.
    J Cell Biol; 1999 Jun 28; 145(7):1471-82. PubMed ID: 10385526
    [Abstract] [Full Text] [Related]

  • 18. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.
    Micheau O, Tschopp J.
    Cell; 2003 Jul 25; 114(2):181-90. PubMed ID: 12887920
    [Abstract] [Full Text] [Related]

  • 19. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.
    Hsu H, Shu HB, Pan MG, Goeddel DV.
    Cell; 1996 Jan 26; 84(2):299-308. PubMed ID: 8565075
    [Abstract] [Full Text] [Related]

  • 20. Caspase-8 and caspase-10 activate NF-kappaB through RIP, NIK and IKKalpha kinases.
    Shikama Y, Yamada M, Miyashita T.
    Eur J Immunol; 2003 Jul 26; 33(7):1998-2006. PubMed ID: 12884866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.